Camilla M. Grunewald

Author

Heinrich Heine University Düsseldorf ORCID

Also Known As

C GRUNEWALD, C Grunewald, C Grünewald, C. Grunewald, C. M. Grunewald, C. Marisa Grunewald, C.M. Grunewald, Camilla Grunewald, Camilla M. Grunewald, Camilla Marisa Grunewald

Publications

362

Citations

H-Index

Concepts

All Affiliations

Heinrich Heine University Düsseldorf Heidelberg University Düsseldorf University Hospital University of Duisburg-Essen University Hospital Münster

About

Camilla M. Grunewald is an author at Heinrich Heine University Düsseldorf specializing in medicine, oncology, and cancer research.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	3	3	49
2	Immunology	2	2	28
3	Pathology	1	1	11
4	Cancer Cell Biology	1	1	11
5	Cancer Genetics	1	1	11

Camilla M. Grunewald

Publications

301

Citations

H-Index

Page 1

	Year	Citations
<i>NECTIN4</i> Amplification Is Frequent in Solid Tumors and Predicts Enfortumab Vedotin Response in Metastatic Urothelial Cancer Niklas Klümper, Ngoc Khanh Tran, Stefanie Zschäbitz, Journal of Clinical Oncology	2024	95
Rapid Identification and Susceptibility Testing of Candida spp. from Positive Blood Cultures by Combination of Direct MALDI-TOF Mass Spectrometry and Direct Inoculation of Vitek 2 Evgeny A. Idelevich, Camilla M. Grunewald, Jörg Wüllenweber, PLoS ONE	2014	70
Epigenetic Priming of Bladder Cancer Cells With Decitabine Increases Cytotoxicity of Human EGFR and CD44v6 CAR Engineered T-Cells Camilla M. Grunewald, Corinna Haist, Carolin König, Frontiers in Immunology	2021	33
Optimal pathological response after neoadjuvant chemotherapy for muscle‐invasive bladder cancer: results from a global, multicentre collaboration Praful Ravi, Gregory R. Pond, Leonidas Nikolaos Diamantopoulos, British Journal of Urology	2021	27
BTA stat®, NMP22® BladderChek®, UBC® Rapid Test, and CancerCheck® UBC® rapid VISUAL as urinary marker for bladder cancer: Final results of a German multicenter study Thorsten Ecke, Christina J. Meisl, Thorsten Schlomm, Urologic Oncology Seminars and Original Investigations Urological ResearchUrologyGenitourinary CancerCancer DetectionNmp22® Bladderchek®	2023	21
Engineering a single-chain variable fragment of cetuximab for CAR T-cell therapy against head and neck squamous cell carcinomas Corinna Haist, Zoe Poschinski, Arthur Bister, Oral Oncology Cancer ImmunosurveillanceSingle-chain Variable FragmentMedicineImmunologyImmune Checkpoint Inhibitor	2022	17
Tumor immunotherapy—the potential of epigenetic drugs to overcome resistance Camilla M. Grunewald, Wolfgang A. Schulz, Margaretha A. Skowron, Translational Cancer Research	2018	17
Occurrence of <i>NECTIN4</i> amplification in solid tumors and enfortumab vedotin response in metastatic urothelial cancer. Niklas Klümper, Ngoc Khanh Tran, Stefanie Zschaebitz, Journal of Clinical Oncology Solid TumorsImmunologyPathologyAmplification FrequencyCancer Biology	2024	11
Using Circulating Tumor DNA To Guide Adjuvant Therapy in Bladder Cancer: IMvigor010 and IMvigor011 Camilla M. Grunewald, Günter Niegisch, Peter Albers European Urology Focus	2022	10

Page 1